Profound Medical Corp.(PROF)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Profound Medical Corp. (PROF) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PROF at 29.3/100 on a 32-signal composite quality model, placing it at rank #2,532 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Profound Medical Corp. reports quarterly revenue of $2.5M, net income of $-9.5M. Top institutional holders of PROF by reported 13-F value include FIL Ltd, GAGNON SECURITIES, ROYCE & ASSOCIATES, based on the most recent SEC filings. PROF trades on the Nasdaq exchange and files with the SEC under CIK 1628808. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PROF daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Profound Medical Corp. directly from SEC EDGAR.

AI Quality Score

29.3/100

AI Rank

#2,532

Revenue

$2.5M

Net Income

$-9.5M

PROF key financials by period

Profound Medical Corp. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$16.1M$-42.6M
FY 202410-K$10.7M$-27.8M
FY 202310-K$7.2M$-28.3M
FY 202210-K$6.7M
FY 202140-F$6.9M
FY 202040-F$7.3M

Institutions holding PROF

Institutional investors reporting a position in Profound Medical Corp. on SEC Form 13F.
InstitutionSharesValueReported
FIL Ltd2,370,000$15.8M2026-06-30
GAGNON SECURITIES1,960,074$13.0M2026-06-30
ROYCE & ASSOCIATES1,199,564$8.0M2026-06-30
Timelo Investment Management1,114,967$7.4M2026-06-30
Gagnon Advisors962,186$6.4M2026-06-30
Rosalind Advisors828,118$5.5M2026-06-30
Z3 Capital Partners820,941$5.5M2026-06-30
LETKO, BROSSEAU & ASSOCIATES935,725$5.4M2026-06-30
MMCAP International SPC671,356$4.5M2026-06-30
ARDSLEY ADVISORY PARTNERS575,000$3.8M2026-06-30
PROF

Profound Medical Corp.

PROF
NasdaqSmall CapHealthcare

13F Pro Quality Score

29.3/100

Rank #2,532 of 2,961 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$2.48M

Net Income

Q2 2026
EDGAR

$-9.54M

EPS (Diluted)

Q2 2026
EDGAR

$-0.26

Top Institutional Holders

as of Q2 2026
$106.60M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…